PMID- 27910782 OWN - NLM STAT- MEDLINE DCOM- 20170207 LR - 20181202 IS - 2162-6537 (Electronic) IS - 0731-8898 (Linking) VI - 35 IP - 3 DP - 2016 TI - Chemoprevention of Colon Cancer through Inhibition of Angiogenesis and Induction of Apoptosis by Nonsteroidal Anti-Inflammatory Drugs. PG - 273-289 AB - Cancer cells require nourishment for the growth of the primary tumor mass and spread of the metastatic colony. These needs are fulfilled by tumor-associated neovasculature known as angiogenesis, which also favors the transition from hyperplasia to neoplasia, that is, from a state of cellular multiplication to uncontrolled proliferation. Therefore, targeting angiogenesis is profitable as a mechanism to inhibit tumor growth. Furthermore, it is important to understand the cross-communication between vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in the neoplastic and proinflammatory milieu. We studied the role of two important chemokines (monocyte chemoattractant protein-1 [MCP-1] and macrophage inflammatory protein-1beta [MIP-1beta]) along with VEGF and MMPs in nonsteroidal anti-inflammatory drug (NSAID)-induced chemopreventive effects in experimental colon cancer in rats. 1,2-Dimethylhydrazine dihydrochloride (DMH) was used as cancer-inducing agent and three NSAIDs (celecoxib, etoricoxib, and diclofenac) were given orally as chemopreventive agents. Analysis by immunofluorescence and western blotting shows that the expression of VEGF, MMP-2, and MMP-9 was found to be significantly elevated in the DMH- treated group and notably lowered by NSAID coadministration. The expression of MCP-1 was found to be markedly decreased, whereas that of MIP-1beta increased after NSAID coadministration. NSAID coadministration was also able to induce apoptosis, confirmed using studies by Hoechst/propidium iodide (PI) costaining and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. Results from the present study indicate the potential role of these chemokines along with VEGF and MMPs against angiogenesis in DMH-induced cancer. The inhibition of angiogenesis and induction of apoptosis by NSAIDs were found to be possible mechanisms in the chemoprevention of colon cancer. FAU - Ghanghas, Preety AU - Ghanghas P AD - Department of Biophysics, Panjab University, Chandigarh, India 160014. FAU - Jain, Shelly AU - Jain S AD - Department of Biophysics, Panjab University, Chandigarh, India 160014. FAU - Rana, Chandan AU - Rana C AD - Department of Biophysics, Panjab University, Chandigarh, India 160014. FAU - Sanyal, Sankar Nath AU - Sanyal SN AD - Department of Biophysics, Panjab University, Chandigarh, India 160014. LA - eng PT - Journal Article PL - United States TA - J Environ Pathol Toxicol Oncol JT - Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer JID - 8501420 RN - 0 (Anti-Inflammatory Agents, Non-Steroidal) RN - 0 (Anticarcinogenic Agents) RN - 0 (Cyclooxygenase 2 Inhibitors) RN - 0 (Pyridines) RN - 0 (Sulfones) RN - 144O8QL0L1 (Diclofenac) RN - JCX84Q7J1L (Celecoxib) RN - WRX4NFY03R (Etoricoxib) SB - IM MH - Animals MH - Anti-Inflammatory Agents, Non-Steroidal/*pharmacology/therapeutic use MH - Anticarcinogenic Agents/*pharmacology MH - Apoptosis/*drug effects MH - Celecoxib/pharmacology/therapeutic use MH - Colonic Neoplasms/*drug therapy/etiology MH - Cyclooxygenase 2 Inhibitors/*pharmacology MH - Diclofenac/pharmacology/therapeutic use MH - Etoricoxib MH - Female MH - Neovascularization, Pathologic/*drug therapy/etiology MH - Pyridines/pharmacology/therapeutic use MH - Rats MH - Rats, Sprague-Dawley MH - Sulfones/pharmacology/therapeutic use EDAT- 2016/12/03 06:00 MHDA- 2017/02/09 06:00 CRDT- 2016/12/03 06:00 PHST- 2016/12/03 06:00 [entrez] PHST- 2016/12/03 06:00 [pubmed] PHST- 2017/02/09 06:00 [medline] AID - 2d1506ed13a32809,396d206c5b008734 [pii] AID - 10.1615/JEnvironPatholToxicolOncol.2016015704 [doi] PST - ppublish SO - J Environ Pathol Toxicol Oncol. 2016;35(3):273-289. doi: 10.1615/JEnvironPatholToxicolOncol.2016015704.